Cancer is often driven by genetic and epigenetic alterations that affect regulatory elements. Mutations, deletions, or amplifications in these regions can lead to the activation of oncogenes or the inactivation of tumor suppressor genes. For example, mutations in the promoter region of the TERT gene are common in several cancers and result in increased telomerase activity, contributing to cancer cell immortality.
